Description
Wearable subcutaneous drug delivery devices are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. While the early patch pumps focused on insulin delivery, the market has evolved to include a growing number of devices have been designed and developed to API agnostic. This report analyzes important therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.
